Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance

Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	David W. Wareham, David C. Bean, Priyanka Khanna, Enid Hennessy, D. Krahé, A. Ely, M. Millar
Formáid:	Artigo
Teanga:	Béarla
Foilsithe / Cruthaithe:	2008
Rochtain ar líne:	https://doi.org/10.1007/s10096-008-0473-y https://link.springer.com/content/pdf/10.1007/s10096-008-0473-y.pdf
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
de réir: Balkan, Ilker Inanc, et al.
Foilsithe / Cruthaithe: (2015)

Bloodstream infections due to Peptoniphilus spp.: report of 15 cases
de réir: Brown, K, et al.
Foilsithe / Cruthaithe: (2014)

Bloodstream infections due to Peptoniphilus spp.: report of 15 cases
de réir: Kristen Brown, et al.
Foilsithe / Cruthaithe: (2014)

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
de réir: Almasaudi, Saad B.
Foilsithe / Cruthaithe: (2018)

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
de réir: Saad B. Almasaudi
Foilsithe / Cruthaithe: (2016)

Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical Outcomes
de réir: Chopra, Teena, et al.
Foilsithe / Cruthaithe: (2013)

Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical Outcomes
de réir: Teena Chopra, et al.
Foilsithe / Cruthaithe: (2013)

Characterization and molecular epidemiology of extensively prevalent nosocomial isolates of drug-resistant Acinetobacter spp
de réir: Andreia Carvalho, et al.
Foilsithe / Cruthaithe: (2016)

Emergence of multi drug resistant nonfermentative Acinetobacter spp in a tertiary care hospital
de réir: Amol, Shyamkuwar, et al.
Foilsithe / Cruthaithe: (2012)

Risk Factors and Outcomes for Patients with Bloodstream Infection Due to Acinetobacter baumannii-calcoaceticus Complex
de réir: Chopra, Teena, et al.
Foilsithe / Cruthaithe: (2014)

Risk Factors and Outcomes for Patients with Bloodstream Infection Due to Acinetobacter baumannii-calcoaceticus Complex
de réir: Teena Chopra, et al.
Foilsithe / Cruthaithe: (2014)

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
de réir: Bergogne-Bérézin, E, et al.
Foilsithe / Cruthaithe: (1996)

Epidemiology and Infection Control Implications of Acinetobacter spp. in Hong Kong
de réir: Houang, Elizabeth T. S., et al.
Foilsithe / Cruthaithe: (2001)

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
de réir: E Bergogne-Bérézin, et al.
Foilsithe / Cruthaithe: (1996)

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
de réir: Eugenie Bergogne‐Berezin, et al.
Foilsithe / Cruthaithe: (1996)

Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006
de réir: Bean, David C, et al.
Foilsithe / Cruthaithe: (2008)

Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006
de réir: David C. Bean, et al.
Foilsithe / Cruthaithe: (2008)

Epidemiological impact of the antimicrobial therapy on Acinetobacter spp. isolated from ITU patients
de réir: Nikodemski, T, et al.
Foilsithe / Cruthaithe: (1998)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
de réir: Niu, Tianshui, et al.
Foilsithe / Cruthaithe: (2019)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
de réir: Tianshui Niu, et al.
Foilsithe / Cruthaithe: (2019)

Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai
de réir: Yang, Zhi-Tao, et al.
Foilsithe / Cruthaithe: (2014)

Epidemiology, species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai
de réir: Zhitao Yang, et al.
Foilsithe / Cruthaithe: (2014)

Molecular Epidemiology of Multi-Drug Resistant Acinetobacter baumannii Isolated in Shandong, China
de réir: Jiang, Meijie, et al.
Foilsithe / Cruthaithe: (2016)

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases
de réir: Wareham, David W, et al.
Foilsithe / Cruthaithe: (2006)

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
de réir: David W. Wareham, et al.
Foilsithe / Cruthaithe: (2006)

Risk factors to bloodstream infection due multidrug-resistant Results Acinetobacter baumanni in colonized patients in the ICU
de réir: Passos, R, et al.
Foilsithe / Cruthaithe: (2011)

Risk factors to bloodstream infection due multidrug-resistant Results Acinetobacter baumanni in colonized patients in the ICU
de réir: Rogério da Hora Passos, et al.
Foilsithe / Cruthaithe: (2011)

Shewanella spp. Bloodstream Infections in Queensland, Australia
de réir: Laupland, Kevin B., et al.
Foilsithe / Cruthaithe: (2022)

Acinetobacter spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology
de réir: Mohd. Rani, Farahiyah, et al.
Foilsithe / Cruthaithe: (2017)

In Vitro Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
de réir: Wareham, D. W., et al.
Foilsithe / Cruthaithe: (2006)

Molecular Epidemiology of Aminoglycosides Resistance in Acinetobacter Spp. with Emergence of Multidrug-Resistant Strains
de réir: Moniri, R, et al.
Foilsithe / Cruthaithe: (2010)

Epidemiology and Infection Control Implications of <i>Acinetobacter</i> spp. in Hong Kong
de réir: Elizabeth T. S. Houang, et al.
Foilsithe / Cruthaithe: (2001)

Acinetobacter spp. in Gunshot Injuries
de réir: Elston, James W.T., et al.
Foilsithe / Cruthaithe: (2008)

An ionophore breaks the multi-drug-resistance of Acinetobacter baumannii
de réir: De Oliveira, David M.P., et al.
Foilsithe / Cruthaithe: (2022)

Catheter-related bloodstream infection due to Acinetobacter ursingii in a hemodialysis patient: case report and literature review
de réir: Daniel, Arsanios Martin, et al.
Foilsithe / Cruthaithe: (2021)

Effect of Inhaled Colistin on the Treatment of Ventilator-Associated Pneumonia due to Multi-drug Resistant Acinetobacter
de réir: Moradi Moghaddam, Omid, et al.
Foilsithe / Cruthaithe: (2019)

Bloodstream infection by Acinetobacter radioresistens: the first case report in Brazil
de réir: Lopes, Maria Carolina, et al.
Foilsithe / Cruthaithe: (2020)

Bloodstream infection by Acinetobacter radioresistens: the first case report in Brazil
de réir: Maria Carolina Soares Lopes, et al.
Foilsithe / Cruthaithe: (2019)

Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals
de réir: Wang, Hui, et al.
Foilsithe / Cruthaithe: (2007)

Longitudinal Epidemiology of Multidrug Resistant (MDR) Acinetobacter spp. in a Tertiary-Care Hospital
de réir: Baang, Ji Hoon, et al.
Foilsithe / Cruthaithe: (2011)